Christopher Maucourant

Christopher Maucourant

Auto-generated profile, based on publicly available information

Christopher Maucourant

Sorbonne Université, UPMC, Inserm U1135, CNRS ERL 8255, Centre d’Immunologie et des Maladies Infectieuses , Paris

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Science Immunology
Verified
Journal Article
Open access
PDF file
CMChristopher Maucourant
Christopher Maucourant
IFIva Filipovic
Iva Filipovic
APAndrea Ponzetta
Andrea Ponzetta
SASoo Aleman
Soo Aleman
MCMartin Cornillet
Martin Cornillet
NBNiklas Björkström
Niklas Björkström
Understanding innate immune responses in COVID-19 is important to decipher mechanisms of host responses and interpret disease pathogenesis. Natural killer (NK) cells are innate effector lymphocytes that respond to acute viral infections but might also contribute to immunopathology. Using 28-color flow cytometry, we here reveal strong NK cell activation across distinct subsets in peripheral blood of COVID-19 patients. This pattern was mirrored in scRNA-seq signatures of NK cells in bronchoalveolar lavage from COVID-19 patients. Unsupervised high-dimensional analysis of peripheral blood NK cells furthermore identified distinct NK cell immunotypes that were linked to disease severity. Hallmarks of these immunotypes were high expression of perforin, NKG2C, and Ksp37, reflecting increased presence of adaptive NK cells in circulation of patients with severe disease. Finally, arming of CD56bright NK cells was observed across COVID-19 disease states, driven by a defined protein-protein interaction network of inflammatory soluble factors. This study provides a detailed map of the NK cell activation landscape in COVID-19 disease.

31 January 2019 in Viruses
Verified
Journal Article
Open access
PDF file
CMChristopher Maucourant
Christopher Maucourant
CPCaroline Petitdemange
Caroline Petitdemange
HYHans Yssel
Hans Yssel
VVVincent Vieillard
Vincent Vieillard
The recent explosive pandemic of chikungunya virus (CHIKV) followed by Zika (ZIKV) virus infections occurring throughout many countries represents the most unexpected arrival of arthropod-borne viral diseases in the past 20 years. Transmitted through the bite of Aedes mosquitoes, the clinical picture associated with these acute arbovirus infections, including Dengue (DENV), CHIKV and ZIKV, ranges from classical febrile illness to life-threatening disease. Whereas ZIKV and CHIKV-mediated infections have previously been recognized as relatively benign diseases, in contrast to Dengue fever, recent epidemic events have brought waves of increased morbidity and mortality leading to a serious public health problem. Although the host immune response plays a crucial role in controlling infections, it may also promote viral spread and immunopathology. Here, we review recent developments in our understanding of the immune response, with an emphasis on the early antiviral immune response mediated by natural killer cells and emphasize their Janus-faced effects in the control of arbovirus infection and pathogenesis. Improving our understanding knowledge on of the mechanisms that control viral infection is crucial in the current race against the globalization of arbovirus epidemics.

1 February 2019 in EBioMedicine
Verified
Journal Article
Open access
NWNadia Wauquier
Nadia Wauquier
CPCaroline Petitdemange
Caroline Petitdemange
NTNadine Tarantino
Nadine Tarantino
CMChristopher Maucourant
Christopher Maucourant
MCMoinya Coomber
Moinya Coomber
VVVincent Vieillard
Vincent Vieillard
Lassa virus (LASV) is the etiologic agent of an acute hemorrhagic fever endemic in West Africa. Natural killer (NK) cells control viral infections in part through the interaction between killer cell immunoglobulin-like receptors (KIRs) and their ligands. LASV infection is associated with defective immune responses, including inhibition of NK cell activity in the presence of MHC-class 1+-infected target cells. We compared individual KIR and HLA-class 1 genotypes of 68 healthy volunteers to 51 patients infected with LASV in Sierra Leone, including 37 survivors and 14 fatalities. Next, potential HLA-C1, HLA-C2, and HLA-Bw4 binding epitopes were in silico screened among LASV nucleoprotein (NP) and envelope glycoprotein (GP). Selected 10-mer peptides were then tested in peptide-HLA stabilization, KIR binding and polyfunction assays. LASV-infected patients were similar to healthy controls, except for the inhibitory KIR2DL2 gene. We found a specific increase in the HLA-C1:KIR2DL2 interaction in fatalities (10/11) as compared to survivors (12/19) and controls (19/29). We also identified that strong of NP and GP viral epitopes was only observed with HLA-C molecules, and associated with strong inhibition of degranulation in the presence of KIR2DL+ NK cells. This inhibitory effect significantly increased in the presence of the vGP420 variant, detected in 28.1% of LASV sequences. Our finding suggests that presentation of specific LASV epitopes by HLA-C alleles to the inhibitory KIR2DL2 receptor on NK cells could potentially prevent the killing of infected cells and provides insights into the mechanisms by which LASV can escape NK-cell-mediated immune pressure.

1 September 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CMChristopher Maucourant
Christopher Maucourant
GQGabriel Andrade Nonato Queiroz
Gabriel Andrade Nonato Queiroz
ACAurélien CORNEAU
Aurélien CORNEAU
LGLuana Leandro Gois
Luana Leandro Gois
AMAïda Meghraoui-Kheddar
Aïda Meghraoui-Kheddar
VVVincent Vieillard
Vincent Vieillard
Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged as a global concern because of its impact on human health. ZIKV infection during pregnancy can cause microcephaly and other severe brain defects in the developing fetus and there have been reports of the occurrence of Guillain-Barré syndrome in areas affected by ZIKV. NK cells are activated during acute viral infections and their activity contributes to a first line of defense because of their ability to rapidly recognize and kill virus-infected cells. To provide insight into NK cell function during ZIKV infection, we have profiled, using mass cytometry, the NK cell receptor-ligand repertoire in a cohort of acute ZIKV-infected female patients. Freshly isolated NK cells from these patients contained distinct, activated, and terminally differentiated, subsets expressing higher levels of CD57, NKG2C, and KIR3DL1 as compared with those from healthy donors. Moreover, KIR3DL1+ NK cells from these patients produced high levels of IFN-γ and TNF-α, in the absence of direct cytotoxicity, in response to in vitro stimulation with autologous, ZIKV-infected, monocyte-derived dendritic cells. In ZIKV-infected patients, overproduction of IFN-γ correlated with STAT-5 activation (r = 0.6643; p = 0.0085) and was mediated following the recognition of MHC class 1–related chain A and chain B molecules expressed by ZIKV-infected monocyte-derived dendritic cells, in synergy with IL-12 production by the latter cells. Together, these findings suggest that NK cells contribute to the generation of an efficacious adaptive anti-ZIKV immune response that could potentially affect the outcome of the disease and/or the development of persistent symptoms. Key Points NK cells from ZIKV-infected patients produced high levels of IFN-γ and TNF-α. Overproduction of IFN-γ by NK cells is correlated with STAT-5 activation. Cytokine production is mediated by MIC molecules expressed by ZIKV+ cells.

19 November 2019 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
CPCaroline Petitdemange
Caroline Petitdemange
CMChristopher Maucourant
Christopher Maucourant
NTNadine Tarantino
Nadine Tarantino
JRJuliana Rey
Juliana Rey
VVVincent Vieillard
Vincent Vieillard
Dengue virus (DENV) is the most widespread arbovirus worldwide and is responsible for major outbreaks. The host's immune response plays a crucial role in controlling this infection but might also contribute to the promotion of viral spread and immunopathology. In response to DENV infection, NK cells preferentially produce cytokines and are cytotoxic in the presence of specific antibodies. Here, we identified that DENV‐2 inhibits glycogen synthase kinase 3 (GSK‐3) activity to subsequently induce MHC class‐1‐related chain (MIC) A and MIC‐B expression and IL‐12 production in monocyte‐derived DCs, independently of the STAT‐3 pathway. The inhibition of GSK‐3 by DENV‐2 or small molecules induced MIC‐A/B expression on monocyte‐derived DCs, resulting in autologous NK cells of a specific increase in IFN‐γ and TNF‐α production, in the absence of direct cytotoxicity. Together, these findings identified GSK‐3 as a regulator of MIC‐A/B expression and suggested its role in DENV‐2 infection to specifically induce cytokine production by NK cells.

4 April 2026
Verified
Thesis
Closed access
CMChristopher Maucourant
Christopher Maucourant
L'histoire récente à été marquée par des épidémies récentes de dengue (Denv), Chikungunya (CHIKV) et Zika (ZIKV). Bien que ces maladies soient largement asymptomatiques, elles peuvent générer de sérieuses complications comme des formes chroniques d'arthralgies et peuvent causer des hémorragies pouvant conduire au décès (Majoritairement DENV), des microcéphalies (Maj. ZIKV) et des Syndromes de Guillain-Barré (Zikv et Chikv). Ces épidémies récentes ont poussé l'OMS à classer ces maladies comme maladies à déclaration obligatoire. A ce jour aucun traitement spécifique existe contre ces maladies rendant prioritaire la compréhension de l'immunité dirigée contre ces virus. Bien que peu de choses soient connues sur l'immunité dirigée contre ces virus, certaines études ont montré le rôle de l'immunité innée dans la clairance de ces infections. Parmi les cellules de l'immunité innée on trouve les cellules Natural Killer qui ont la capacité de s'activer sans immunisation préalable via la reconnaissance de molécules de stresse. Une fois activées, ces cellules ont la capacité de produire des cytokines afin d'induire l'activation de l'immunité adaptatives et de tuer les cellules infectées. Les premiers travaux menés au laboratoire ont montré un découplage des fonctions NK au cours de ces infections : Cytoxicité uniquement au cours des infections par CHIKV, production de cytokines au cours des infections par DENV. Nous nous sommes intéressé à créer des modèles d'étude des interactions entre les cellules NK et des cibles infectées par ces virus afin de caractériser les couples ligands/récepteurs mis en jeu ainsi que les voies de signalisation impliquées dans ce découplage fonctionnel.